IPM Magazine

Volume 09, Issue No. 2, April 2022

Despite witnessing great leaps in recent years in how we can measure and quantify biological systems with great accuracy and precision – we’re only at the beginning stages of interrogating the vast complexity of the genome and cascading proteome, transcriptome, metabolome and as we cover later in this issue – the ‘connectome’. Not knowing enough, is, I would argue, a position of strength not weakness, propelling us to discover the ‘unknown unknowns’, pushing us to find solutions to intractable problems.

The focus of this issue is centered on the rapidly evolving area of minimal residual disease but as was pointed out in one of our interviews, when you’re looking at numbers close to a million or so cancer cells it’s hard to argue there is anything minimal about that analysis at all.

Damian Doherty

Editor in Chief

Browse the print magazine as a flipbook

Website Content from This Issue

Circulating Tumor DNA is Increasingly Effective in Cancer Healthcare

Cancer cells on dna stand background. 3d illustration

MRD: The Future Foundation of Solid Tumor Trials


How Duplex Sequencing Can Improve MRD Detection

DNA strand and Cancer Cell to visualize cancer genetics

The Changing Face of Newborn Screening


Relatively Speaking: Unexpected Detours, Can Inconclusive Prenatal Genetic Tests Save Lives?

digital heads

Asked and Answered: Cartography of the Brain: Narayanan “Bobby” Kasthuri on Connectomics

Light trails coming from African American's head

Growing Pains

Close up of a cancer cell - oncology target 3d illustration

Advancing the Field of Polygenic Risk Score Testing Applications from the Lab to Your Smartphone

Genetic research

Vested Interest: Investing in Diagnostics for Precision Medicine

IPM Vested Interest logo

A Conversation with Isabelle de Cremoux, CEO and Managing Partner of European Life Science VC Seventure Partners

Researcher symbolizes risk of venture capital

Valunomics: Medicare Policy: How It Can Boost or Block Innovation

Genetic Research, DNA profile reflected in a test tube containing a sample

Extracellular Signaling Pathway Inhibits SARS-CoV-2 mRNA Expression

William Haseltine

Humain Lens: Protecting Patient Privacy in Clinical Trials with Artificial Intelligence

Digital eye. Green matrix background

The Future You: How Artificial Intelligence Can Help You Get Healthier, Stress Less, and Live Longer

The Future You cover cropped

Making Precision Oncology Accessible

Canexia Health Lab

MRD Testing in Solid Tumors Using RaDaR™ by NeoGenomics


Unlocking the Full Potential of MRD Testing in Patients with Cancer

Migrating Breast Cancer Cell
Inside Precision Medicine